|
1
|
Wasserman M, Baxter NN, Rosen B, Burnstein
M and Halverson AL: Systematic review of internet patient
information on colorectal cancer surgery. Dis Colon Rectum.
57:64–69. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang W, Lee DY and Ben-David Y: The roles
of microRNAs in tumorigenesis and angiogenesis. Int J Physiol
Pathophysiol Pharmacol. 3:140–155. 2011.PubMed/NCBI
|
|
3
|
Hamaya Y, Yoshida K, Takai T, Ikuma M,
Hishida A and Kanalka S: Factors that contribute to faecal
cyclooxygenase-2 mRNA expression in subjects with colorectal
cancer. Br J Cancer. 102:916–921. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mo ZH, Wu XD, Li S, Fei BY and Zhang B:
Expression and clinical significance of microRNA-376a in colorectal
cancer. Asian Pac J Cancer Prev. 15:9523–9527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fayyad-Kazan H, Bitar N, Najar M, Lewalle
P, Fawad-Kazan M, Badran R, Hamade E, Daher A, Hussein N, ElDirani
R, et al: Circulating miR-150 and miR-342 in plasma are novel
potential biomarkers for acute myeloid leukemia. J Transl Med.
11:312013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye JJ and Cao J: MicroRNAs in colorectal
cancer as markers and targets-Recent advances. World J
Gastroenterol. 20:4288–4299. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oglesby IK, McElvaney NG and Greene CM:
MicroRNAs in inflammatory lung disease-master regulators or target
practice? Respir Res. 11:1482010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holloway JW, Francis S Savarimuthu, Fong
KM and Yang IA: Genomics and the respiratory effects of air
pollution exposure. Respirology. 17:590–600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Small EM and Olson EN: Pervasive roles of
microRNAs in cardiovascular biology. Nature. 469:336–342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Almeida MI, Nicoloso MS, Zeng L, Ivan C,
Spizzo R, Gafa R, Xiao L, Zhang X, Vannini I, Fanini F, et al:
Strand-specific miR-28-5p and miR-28-3p have distinct effects in
colorectal cancer cells. Gastroenterology. 142:886–896. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou S, Ye W, Ren J, Shao Q, Qi Y, Liang J
and Zhang M: MicroRNA-381 increases radiosensitivity in esophageal
squamous cell carcinoma. Am J Cancer Res. 5:267–277.
2014.PubMed/NCBI
|
|
12
|
Ye J, Wu X, Wu D, Wu P, Ni C, Zhang Z,
Chen Z, Qiu F, Xu J and Huang J: miRNA-27b targets vascular
endothelial growth factor C to inhibit tumor progression and
angiogenesis in colorectal cancer. PLoS One. 8:e606872013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tong AW and Nemunaitis J: Modulation of
miRNA activity in human cancer: A new paradigm for cancer gene
therapy? Cancer Gene Ther. 15:341–355. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xiao B, Guo J, Miao Y, Jiang Z, Huan R,
Zhang Y, Li D and Zhong J: Detection of miR-106a in gastric
carcinoma and its clinical significance. Clin Chim Acta.
400:97–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu
FQ, Hu R and Wang MS: miR-106a promotes growth and metastasis of
non-small cell lung cancer by targeting PTEN. Int J Clin Exp
Pathol. 8:3827–3834. 2015.PubMed/NCBI
|
|
16
|
Kim YW, Kim EY, Jeon D, Liu JL, Kim HS,
Choi JW and Ahn WS: Differential microRNA expression signatures and
cell type-specific association with Taxol resistance in ovarian
cancer cells. Drug Des Devel Ther. 8:293–314. 2014.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu D, Zhang S, Du W, Zhang J, Fan Z, Hao
H, Liu Y, Zhao X, Qin T and Zhu H: Expression of intracellular
interferon-alpha confers antiviral properties in transfected bovine
fetal fibroblasts and does not affect the full development of SCNT
embryos. PLoS One. 9:e944442014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Meng L, Fan Z, Liu B, Pei Y and
Zhao Z: Expression of plasma miR-106a in colorectal cancer and its
clinical significance. Nan Fang Yi Ke Da Xue Xue Bao. 34:354–357.
2014.(In Chinese). PubMed/NCBI
|
|
20
|
Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C,
Quan L, Bai J and Xu N: miR-106a is frequently upregulated in
gastric cancer and inhibits the extrinsic apoptotic pathway by
targeting FAS. Mol Carcinog. 52:634–646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan R, Zhi Q, Zhao H, Han Y, Gao L, Wang
B, Kou Z, Guo Z, He S, Xue X and Hu H: Upregulated expression of
miR-106a by DNA hypomethylation plays an oncogenic role in
hepatocellular carcinoma. Tumour Biol. 36:3093–3100. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li P, Xu Q, Zhang D, Li X, Han L, Lei J,
Duan W, Ma Q, Wu Z and Wang Z: Upregulated miR-106a plays an
oncogenic role in pancreatic cancer. FEBS Lett. 588:705–712. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Wang B, Shi Y, Xu C, Xiao HL, Ma
LN, Xu SL, Yang L, Wang QL, Dang WQ, et al: Oncogenic miR-20a and
miR-106a enhance the invasiveness of human glioma stem cells by
directly targeting TIMP-2. Oncogene. 34:1407–1419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu M, Zhang N and He S: Similarly
up-regulated microRNA-106a in matched formalin-fixed
paraffin-embedded and fresh frozen samples and the dynamic changes
during gastric carcinogenesis and development. Pathol Res Pract.
210:909–915. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schee K, Boye K, Abrahamsen TW, Fodstad Ø
and Flatmark K: Clinical relevance of microRNA miR-21, miR-31,
miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC
Cancer. 12:5052012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Criscitiello C, Sotiriou C and Ignatiadis
M: Circulating tumor cells and emerging blood biomarkers in breast
cancer. Curr Opin Oncol. 22:552–558. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin X, Xu H, Gong W and Deng W: The tumor
cytosol miRNAs, fluid miRNAs, and exosome miRNAs in lung cancer.
Front Oncol. 4:3572015. View Article : Google Scholar : PubMed/NCBI
|
